tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Lepu Biopharma Co. Ltd. Class H (2157) Income Statement

Compare
2 Followers

Lepu Biopharma Co. Ltd. Class H Income Statement

Last quarter (Q4 2024), Lepu Biopharma Co. Ltd. Class H's total revenue was ¥117.26M, an increase of 66.93% from the same quarter last year. In Q4, Lepu Biopharma Co. Ltd. Class H's net income was ¥-109.47M. See Lepu Biopharma Co. Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 367.79M¥ 225.35M¥ 15.57M¥ 0.00¥ 0.00
Gross Profit
¥ 292.97M¥ 197.07M¥ 13.57M¥ 0.00¥ 0.00
Operating Expenses
¥ 683.74M¥ 192.28M¥ 655.60M¥ 944.08M¥ 449.32M
Depreciation and Amortization
¥ 83.91M¥ 102.57M¥ 95.45M¥ 77.18M¥ 63.69M
EBITDA
¥ -311.94M¥ 86.95M¥ -596.53M¥ -865.23M¥ -371.01M
Operating Income
¥ -390.76M¥ 4.80M¥ -704.48M¥ -1.01B¥ -520.35M
Other Income/Expenses
¥ -33.43M¥ -35.10M¥ 5.04M¥ -19.23M¥ -93.10M
Pretax Income
¥ -424.19M¥ -30.30M¥ -699.44M¥ -1.03B¥ -613.45M
Net Income
¥ -411.38M¥ -22.10M¥ -689.05M¥ -1.01B¥ -581.85M
Per Share Metrics
Basic EPS
¥ -0.24¥ -0.01¥ -0.42¥ -0.61¥ -0.35
Diluted EPS
¥ -0.24¥ -0.01¥ -0.42¥ -0.61¥ -0.35
Weighted Average Shares Outstanding
1.69B 1.66B 1.64B 1.66B 1.66B
Weighted Average Shares Outstanding (Diluted)
1.69B 1.66B 1.64B 1.66B 1.66B
Currency in CNY

Lepu Biopharma Co. Ltd. Class H Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis